This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Babylon Holdings Beheer

Beheer criteriumcontroles 0/4

De CEO Babylon Holdings is Parsa Parsadoust, benoemd in Jan2013, heeft een ambtstermijn van 10.58 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 7.10M, bestaande uit 8.7% salaris en 91.3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 18.9% van de aandelen van het bedrijf, ter waarde $ 101.18K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.6 jaar en 2.3 jaar.

Belangrijke informatie

Parsa Parsadoust

Algemeen directeur

US$7.1m

Totale compensatie

Percentage CEO-salaris	8.7%
Dienstverband CEO	10.6yrs
Eigendom CEO	18.9%
Management gemiddelde ambtstermijn	1.6yrs
Gemiddelde ambtstermijn bestuur	2.3yrs

Recente managementupdates

Recent updates

Babylon to execute 1-for-25 reverse share split

Nov 09

Babylon Holdings files to sell 145.89M Class A ordinary shares

Oct 17

Babylon receives NYSE notice and gets approval for reverse share split at a consolidation ratio of between 15 and 25

Sep 22

Analyse CEO-vergoeding

Hoe is Parsa Parsadoust's beloning veranderd ten opzichte van Babylon Holdings's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Mar 31 2023	n/a	n/a	-US$256m
Dec 31 2022	US$7m	US$621k	-US$221m
Sep 30 2022	n/a	n/a	-US$213m
Jun 30 2022	n/a	n/a	-US$189m
Mar 31 2022	n/a	n/a	-US$96m
Dec 31 2021	US$651k	US$396k	-US$77m

Compensatie versus markt: De totale vergoeding ($USD 7.10M ) Parsa } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 650.80K ).

Compensatie versus inkomsten: De vergoeding van Parsa is gestegen terwijl het bedrijf verliesgevend is.

CEO

Parsa Parsadoust (57 yo)

10.6yrs

Tenure

US$7,103,722

Compensatie

Dr. Ali Parsadoust is also knwon as Parsa, is the Founder of Babylon Healthcare Services Ltd. and serves as its Chief Executive Officer since January 2013 and its Chairman. He serves as Director of Babylon...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Ali Parsadoust	Founder	10.6yrs	US$7.10m	18.9% $ 101.2k
Paul-Henri Ferrand	Chief Operating Officer	less than a year	US$6.66m	0.55% $ 3.0k
David Humphreys	Chief Financial Officer	less than a year	geen gegevens	0.11% $ 571.7
Samira Lowman	Chief People Officer	2.3yrs	geen gegevens	geen gegevens
Mairi Johnson	Chief Partnerships Officer & Employee Director	6.3yrs	geen gegevens	0.0016% $ 8.6
Aron England	Chief Product Officer	less than a year	geen gegevens	geen gegevens

1.6yrs

Gemiddelde duur

56.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van BBLN.F wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.6 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Ali Parsadoust	Founder	10.6yrs	US$7.10m	18.9% $ 101.2k
Mairi Johnson	Chief Partnerships Officer & Employee Director	7.9yrs	geen gegevens	0.0016% $ 8.6
Eugene Davis	Independent Director	less than a year	geen gegevens	geen gegevens
James Carlson	Member of Executive Advisory Board	2.3yrs	geen gegevens	geen gegevens
John Rowe	Member of Executive Advisory Board	2.3yrs	geen gegevens	geen gegevens
Arnold Milstein	Member of Executive Advisory Board	2.3yrs	geen gegevens	geen gegevens
Thomas Spann	Member of Executive Advisory Board	2.3yrs	geen gegevens	geen gegevens
Sean Slovenski	Member of Executive Advisory Board	2.3yrs	geen gegevens	geen gegevens
Mary Langowski	Member of Executive Advisory Board	2.3yrs	geen gegevens	geen gegevens
Molly Joseph	Member of Executive Advisory Board	2.3yrs	geen gegevens	geen gegevens
David Warren	Independent Non Executive Director	1.9yrs	US$226.43k	0.00063% $ 3.4
Dennis Chornenky	Member of Executive Advisory Board	2.3yrs	geen gegevens	geen gegevens

2.3yrs

Gemiddelde duur

68yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van BBLN.F wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.3 jaar), wat duidt op een nieuw bestuur.

This company listing is no longer active

Babylon Holdings Beheer

Beheer criteriumcontroles 0/4

Belangrijke informatie

Recente managementupdates

Babylon Holdings Limited Announces Board Changes

Global Chief Medical Officer recently sold US$74k worth of stock

Global Chief Medical Officer recently sold US$74k worth of stock

High number of new and inexperienced directors

Babylon Holdings Limited Announces Resignation of Yon Nuta as Chief Product Officer, Effective October 18, 2022

Babylon Hires Andrew Hine as Vice President of the Europe, Middle East, & Africa & Asia Go-To-Market Team

Recent updates

Babylon Holdings Limited Filed for Bankruptcy

Babylon Announces the Receipt of Continued Listing Standards Notice from NYSE and Upcoming Delisting

Babylon Holdings Limited Announces Board Changes

Babylon Holdings Limited announced that it expects to receive $34.5 million in funding from AlbaCore Capital LLP

First quarter 2023 earnings released: US$2.53 loss per share (vs US$5.94 loss in 1Q 2022)

Global Chief Medical Officer recently sold US$74k worth of stock

Global Chief Medical Officer recently sold US$74k worth of stock

Consensus revenue estimates decrease by 16%, EPS upgraded

Full year 2022 earnings: EPS exceeds analyst expectations

Babylon Holdings Limited to Report Q4, 2022 Results on Mar 09, 2023

Babylon Holdings Limited Provides Unaudited Earnings Guidance for the Year Ended December 31, 2022

Consensus estimates of losses per share improve by 10%

Price target decreased to US$2.10

High number of new and inexperienced directors

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

VNV (Cyprus) Limited Engages in Discussions with Babylon Holdings Limited

Babylon to execute 1-for-25 reverse share split

Babylon Holdings Limited announced that it has received $80 million in funding from VNV Global AB (publ), Kinnevik AB and other investors

Babylon Holdings Limited announced that it expects to receive $61.45 million in funding from VNV Global AB (publ), Kinnevik AB and other investors

Babylon Holdings Limited Announces Resignation of Yon Nuta as Chief Product Officer, Effective October 18, 2022

Babylon Holdings files to sell 145.89M Class A ordinary shares

Babylon Holdings Limited to Report Q3, 2022 Results on Nov 10, 2022

Babylon Holdings Reportedly to Sell Meritage IPA Assets in Early 2023

Babylon Hires Andrew Hine as Vice President of the Europe, Middle East, & Africa & Asia Go-To-Market Team

Babylon Receives Share Price Notice from the New York Stock Exchange Due to Non-Compliance with NYSE Rule 802.01C

Babylon receives NYSE notice and gets approval for reverse share split at a consolidation ratio of between 15 and 25

Babylon Holdings Limited Announces Chief Financial Officer Changes

Babylon gets new CFO

Babylon Holdings Denies Acquisition Rumors

Babylon Holdings jumps after report of potential sale process

Second quarter 2022 earnings: EPS misses analyst expectations

Babylon Holdings Limited Provides Guidance for the Twelve Months Ending December 31, 2022

Babylon Holdings Limited Announces Executive Changes

Babylon Holdings Limited, Annual General Meeting, Sep 14, 2022

Babylon Holdings Limited to Report Q2, 2022 Results on Aug 09, 2022

Babylon Holdings Limited Provides Earnings Guidance for the Year 2022

Babylon +2%, expects $100M savings per year

Consensus revenue estimates increase by 11%

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Babylon Holdings Limited Revises Revenue Guidance for the Year 2022

Price target decreased to US$7.30

High number of new and inexperienced directors

Babylon Holdings Limited to Report Q1, 2022 Results on May 12, 2022

Consensus forecasts updated

Full year 2021 earnings: Revenues in line with analyst expectations

No longer forecast to breakeven

Babylon Holdings Limited to Report Q4, 2021 Results on Mar 10, 2022

Babylon Holdings Limited Announces Resignation of Stacy Saal as Chief Operating Officer, Effective February 12, 2022

Babylon Holdings: A Virtual Value-Based Care Leader With Upside

Babylon Holdings Limited (NYSE:BBLN) acquired DayToDay Health.

Babylon Holdings Limited Increases Revenue Guidance for the Full-Year 2022

Forecast to breakeven in 2024

High number of new and inexperienced directors

Babylon Launches AI in Rwanda in Next Step Towards Digitising Healthcare in Rwanda

Third quarter 2021 earnings released: US$0.08 loss per share

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd